Comment on CMS-2026-1255-0001

Summary: The Alliance of Specialty Medicine, representing over 100,000 specialty physicians, supports the proposed rule to extend interoperability and transparency requirements to the prior authorization of drugs. While supporting the expansion, they urge CMS to adopt even shorter decision timeframes, implement enforcement mechanisms for compliance, and maintain formulary information within the proposed APIs to improve continuity of care.